21-46137022-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_206965.2(FTCD):c.1591C>A(p.Leu531Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000502 in 1,613,658 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_206965.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTCD | NM_206965.2 | c.1591C>A | p.Leu531Met | missense_variant | 14/14 | ENST00000397746.8 | NP_996848.1 | |
FTCD | NM_001320412.2 | c.1571C>A | p.Thr524Asn | missense_variant | 14/15 | NP_001307341.1 | ||
FTCD | NM_006657.3 | c.1591C>A | p.Leu531Met | missense_variant | 14/15 | NP_006648.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FTCD | ENST00000397746.8 | c.1591C>A | p.Leu531Met | missense_variant | 14/14 | 1 | NM_206965.2 | ENSP00000380854.3 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000403 AC: 10AN: 248130Hom.: 0 AF XY: 0.0000594 AC XY: 8AN XY: 134708
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1461298Hom.: 1 Cov.: 36 AF XY: 0.0000399 AC XY: 29AN XY: 726928
GnomAD4 genome AF: 0.000144 AC: 22AN: 152360Hom.: 0 Cov.: 33 AF XY: 0.000174 AC XY: 13AN XY: 74504
ClinVar
Submissions by phenotype
Glutamate formiminotransferase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 19, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with FTCD-related conditions. This variant is present in population databases (rs190697279, gnomAD 0.05%). This sequence change replaces leucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 531 of the FTCD protein (p.Leu531Met). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at